The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

U.S. Food and Drug Administration (FDA) approved Wegovy pill from Novo Nordisk. The pill will contain 25 mg of semaglutide—the same compound in the injectable version of Wegovy—to treat overweight or ...

Beginning in January 2026, this pill - developed by Danish pharmaceutical company Novo Nordisk - will become a daily option ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

The Food and Drug Administration has approved Novo Nordisk’s once-daily Wegovy pill, the first oral GLP-1 medicine for ...

The FDA has approved the first pill version of Wegovy, expanding access to one of the most popular and effective weight-loss ...

There’s “quite big news” around weight loss medications circulating right now, says Wajahat Mehal, MD, director of Yale ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk’s weight-loss drug Wegovy, ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Trazodone is a generic prescription drug FDA-approved to treat major depressive disorder in adults. It belongs to a class of antidepressants called serotonin receptor antagonist and reuptake ...

DR tablets are made with a special coating. This coating keeps the tablet from releasing the drug into your system before the tablet passes through your stomach. ER tablets, on the other hand, release ...

The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. This medicine is new or being used differently. Please report side ...